Related Experiment Video

Updated: Jul 15, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
11:02

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1

Published on: May 27, 2016

Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells

Hye-Young Park1, Yoon-Kyung Jeon, Hyun-Jin Shin

  • 1Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea.

Experimental & Molecular Medicine
|April 28, 2007
PubMed

Insights

BubR1 protein is crucial for cell division and preventing cancer. Its expression is regulated by DNA methylation in the promoter region, offering new insights into cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • BubR1 is a key mitotic-checkpoint protein regulating chromosome-spindle attachment and preventing genomic instability.
  • Deregulation of BubR1 expression is implicated in tumorigenesis, but the underlying mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms regulating BubR1 expression, particularly focusing on promoter methylation and polymorphisms.
  • To elucidate how these regulatory mechanisms contribute to human cancer.

Main Methods:

  • Bisulfite sequencing to analyze CpG site methylation status in the BubR1 promoter.
  • Treatment with 5-aza-2'-deoxycytidine to assess the role of DNA methylation.
  • Analysis of a +84A/G polymorphism in the BubR1 gene in colorectal cancer patients.

Main Results:

  • BubR1 expression levels significantly increased upon DNA demethylation.
  • Specific CpG sites in the BubR1 promoter showed an association with expression levels.
  • Demethylation relieved the association of MBD2 and HDAC1 with the BubR1 promoter.
  • A common +84A/G polymorphism in the BubR1 gene did not affect promoter activity.

Conclusions:

  • Differential regulation of BubR1 expression in cancer cells is linked to alterations in promoter hypermethylation patterns.
  • Promoter polymorphisms do not significantly influence BubR1 expression in colorectal cancer.
  • Findings provide novel insights into the epigenetic regulation of BubR1 in human cancer.

More Related Videos

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.